tci Medicare Compliance & Reimbursement - 2021 Issue Q4
Industry Notes: CMS Proposes Reversal of MCIT Final Rule
Subscribe or sign in to view the full article.
Article Overview
This industry note summarizes CMS’s proposed reversal of the Medicare Coverage of Innovative Technology (MCIT) final rule and the agency’s stated reasons for reconsidering how Medicare coverage is extended to breakthrough devices. It is relevant to professionals tracking Medicare coverage policy, FDA breakthrough device pathways, and CMS rulemaking on the definition of reasonable and necessary. The article covers the earlier final rule, the later proposal to repeal it, stakeholder concerns cited by CMS, and the proposed effective date of the new rule.
Why This Topic Matters
The proposed change affects how quickly innovative devices may receive Medicare coverage and signals possible shifts in CMS coverage standards for new technology. Coding, reimbursement, compliance, and reimbursement policy stakeholders may need to monitor the rulemaking process and its final outcome.
What You Will Learn
- The policy background behind CMS’s MCIT final rule
- Why CMS proposed to reconsider or repeal the earlier rule
- How stakeholder concerns shaped the proposed rule
- What the proposal means for Medicare coverage policy
- The timeline of the rulemaking process and effective date mentioned in the article
Who Should Read This
- Medical coders
- Coding auditors
- Revenue cycle professionals
- Compliance staff
- Health policy analysts
- Healthcare administrators
- Device reimbursement specialists
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com